_id

69105d01ccc777a4e85d5891

Ticker

DRTS

Name

Alpha Tau Medical Ltd

Exchange

NASDAQ

Address

Kiryat HaMada St. 5, Jerusalem, Israel, 9777605

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.alphatau.com

Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending clinical studies for brain and other cancers. The company is headquartered in Jerusalem, Israel.

Last Close

5.05

Volume

28152

Current Price

5.11

Change

1.188118811881198

Last Updated

2025-11-29T12:23:13.707Z

Image

data:image/webp;base64,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

Ipo Date

2021-03-08T00:00:00.000Z

Market Cap

338498656

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-0.0020000000000000018

Sentiment Sources

2

Rating

4.5

Target Price

8.5

Strong Buy

2

Buy

2

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

-48642000

Operating Income

48642000

Interest Expense

-

Pretax Income

-11694000

Net Income

-11686000

Eps

-0.13706296124234543

Dividends Per Share

-

Shares Outstanding

85264146

Income Tax Expense

8000

EBITDA

-10454500

Operating Margin

-

Total Other Income Expense Net

-60336000

Cash

3329000

Short Term Investments

68882000

Receivables

-

Inventories

-

Total Current Assets

77100000

Property Plant Equipment

27122000

Total Assets

104694000

Payables

3055000

Short Term Debt

1119000

Long Term Debt

6153000

Total Liabilities

27110000

Equity

77584000

Depreciation

275500

Change In Working Capital

-

Cash From Operations

-

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

-

Net Change In Cash

-8259000

PE

-

PB

5.615578528691484

ROE

-15.062383996700351

ROA

-11.162053221770112

FCF

-

Fcf Percent

-

Piotroski FScore

0

Health Score

37

Deep Value Investing Score

3

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

3

Net Net Investing Score

1

Quality Investing Score

4

Value Investing Score

3

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

-48642000

Quarters > 0 > income Statement > operating Income

48642000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-11694000

Quarters > 0 > income Statement > net Income

-11686000

Quarters > 0 > income Statement > eps

-0.13706296124234543

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

85260087

Quarters > 0 > income Statement > income Tax Expense

8000

Quarters > 0 > income Statement > EBITDA

-10454500

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

-60336000

Quarters > 0 > balance Sheet > cash

3329000

Quarters > 0 > balance Sheet > short Term Investments

68882000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

77100000

Quarters > 0 > balance Sheet > property Plant Equipment

27122000

Quarters > 0 > balance Sheet > total Assets

104694000

Quarters > 0 > balance Sheet > payables

3055000

Quarters > 0 > balance Sheet > short Term Debt

1119000

Quarters > 0 > balance Sheet > long Term Debt

6153000

Quarters > 0 > balance Sheet > total Liabilities

27110000

Quarters > 0 > balance Sheet > equity

77584000

Quarters > 0 > cash Flow > net Income

-11686000

Quarters > 0 > cash Flow > depreciation

275500

Quarters > 0 > cash Flow > change In Working Capital

-

Quarters > 0 > cash Flow > cash From Operations

-

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

-

Quarters > 0 > cash Flow > net Change In Cash

-8259000

Quarters > 0 > ratios > PE

-0.13706296124234543

Quarters > 0 > ratios > PB

5.615578528691484

Quarters > 0 > ratios > ROE

-15.062383996700351

Quarters > 0 > ratios > ROA

-11.162053221770112

Quarters > 0 > ratios > FCF

-

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

37

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

9648000

Quarters > 1 > income Statement > operating Income

-9648000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-10049000

Quarters > 1 > income Statement > net Income

-10114000

Quarters > 1 > income Statement > eps

-0.1258686511218924

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

80353606

Quarters > 1 > income Statement > income Tax Expense

65000

Quarters > 1 > income Statement > EBITDA

-9177000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

-401000

Quarters > 1 > balance Sheet > cash

11703000

Quarters > 1 > balance Sheet > short Term Investments

67996000

Quarters > 1 > balance Sheet > receivables

2525000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

85778000

Quarters > 1 > balance Sheet > property Plant Equipment

24713000

Quarters > 1 > balance Sheet > total Assets

110954000

Quarters > 1 > balance Sheet > payables

2397000

Quarters > 1 > balance Sheet > short Term Debt

1080000

Quarters > 1 > balance Sheet > long Term Debt

6033000

Quarters > 1 > balance Sheet > total Liabilities

24331000

Quarters > 1 > balance Sheet > equity

86623000

Quarters > 1 > cash Flow > net Income

-10114000

Quarters > 1 > cash Flow > depreciation

-

Quarters > 1 > cash Flow > change In Working Capital

-

Quarters > 1 > cash Flow > cash From Operations

-

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

-

Quarters > 1 > cash Flow > net Change In Cash

7026000

Quarters > 1 > ratios > PE

-0.1258686511218924

Quarters > 1 > ratios > PB

4.740160542350184

Quarters > 1 > ratios > ROE

-11.675882848666058

Quarters > 1 > ratios > ROA

-9.115489301872849

Quarters > 1 > ratios > FCF

-

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

37

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

-

Quarters > 2 > income Statement > operating Expenses

9308000

Quarters > 2 > income Statement > operating Income

-9308000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-8592000

Quarters > 2 > income Statement > net Income

-8691000

Quarters > 2 > income Statement > eps

-0.12336251730052493

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

70450897

Quarters > 2 > income Statement > income Tax Expense

99000

Quarters > 2 > income Statement > EBITDA

-9308000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

716000

Quarters > 2 > balance Sheet > cash

5019000

Quarters > 2 > balance Sheet > short Term Investments

46617000

Quarters > 2 > balance Sheet > receivables

1938000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

56786000

Quarters > 2 > balance Sheet > property Plant Equipment

23703000

Quarters > 2 > balance Sheet > total Assets

80928000

Quarters > 2 > balance Sheet > payables

2577000

Quarters > 2 > balance Sheet > short Term Debt

1001000

Quarters > 2 > balance Sheet > long Term Debt

5472000

Quarters > 2 > balance Sheet > total Liabilities

24603000

Quarters > 2 > balance Sheet > equity

56325000

Quarters > 2 > cash Flow > net Income

-8691000

Quarters > 2 > cash Flow > depreciation

-

Quarters > 2 > cash Flow > change In Working Capital

-

Quarters > 2 > cash Flow > cash From Operations

-

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

-

Quarters > 2 > cash Flow > net Change In Cash

-8748000

Quarters > 2 > ratios > PE

-0.12336251730052493

Quarters > 2 > ratios > PB

6.3915505312028404

Quarters > 2 > ratios > ROE

-15.430093209054593

Quarters > 2 > ratios > ROA

-10.739175563463819

Quarters > 2 > ratios > FCF

-

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

34

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

10274000

Quarters > 3 > income Statement > operating Income

-10274000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-9474000

Quarters > 3 > income Statement > net Income

-9476000

Quarters > 3 > income Statement > eps

-0.1351930857154124

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

70092342

Quarters > 3 > income Statement > income Tax Expense

2000

Quarters > 3 > income Statement > EBITDA

-5397500

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

800000

Quarters > 3 > balance Sheet > cash

13724000

Quarters > 3 > balance Sheet > short Term Investments

45876000

Quarters > 3 > balance Sheet > receivables

332000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

64229000

Quarters > 3 > balance Sheet > property Plant Equipment

21543000

Quarters > 3 > balance Sheet > total Assets

86204000

Quarters > 3 > balance Sheet > payables

3531000

Quarters > 3 > balance Sheet > short Term Debt

2021999

Quarters > 3 > balance Sheet > long Term Debt

5561000

Quarters > 3 > balance Sheet > total Liabilities

23538000

Quarters > 3 > balance Sheet > equity

62666000

Quarters > 3 > cash Flow > net Income

-9476000

Quarters > 3 > cash Flow > depreciation

275500

Quarters > 3 > cash Flow > change In Working Capital

-

Quarters > 3 > cash Flow > cash From Operations

-

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

-

Quarters > 3 > cash Flow > net Change In Cash

8251000

Quarters > 3 > ratios > PE

-0.1351930857154124

Quarters > 3 > ratios > PB

5.715569329780105

Quarters > 3 > ratios > ROE

-15.121437462100662

Quarters > 3 > ratios > ROA

-10.992529348986126

Quarters > 3 > ratios > FCF

-

Quarters > 3 > ratios > Piotroski FScore

0

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

37

Valuation > metrics > PE

-0.13706296124234543

Valuation > metrics > PB

5.615578528691484

Valuation > final Score

23.844214713085165

Valuation > verdict

87.2% Overvalued

Profitability > metrics > ROE

-15.062383996700351

Profitability > metrics > ROA

-15.156939040207524

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.3494277170550629

Risk > metrics > Interest Coverage

39.24324324324324

Risk > final Score

100

Risk > verdict

Low

Liquidity > metrics > Current Ratio

18.471490177287972

Liquidity > metrics > Quick Ratio

18.471490177287972

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

32.598394576498166

Prev Valuations > 1

20

Prev Valuations > 2

22.84430670219895

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

15

Prev Risks > 0

16

Prev Risks > 1

8

Prev Risks > 2

50

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-16T22:34:37.428Z